• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受术中高热顺铂治疗的间皮瘤患者中进行大剂量 IV 镁治疗的研究:试验研究和 II 期随机临床试验设计。

High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.

机构信息

Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

出版信息

J Surg Oncol. 2023 Dec;128(7):1141-1149. doi: 10.1002/jso.27412. Epub 2023 Sep 13.

DOI:10.1002/jso.27412
PMID:37702402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592264/
Abstract

INTRODUCTION

Hyperthermic intraoperative cisplatin (HIOC) is associated with acute kidney injury (AKI). Administration of high-dose magnesium attenuates cisplatin-induced AKI (CP-AKI) in animal models but has not been rigorously examined in humans.

METHODS

We tested the feasibility and safety of different doses of magnesium in mesothelioma patients receiving HIOC. In Pilot Study 1, we administered a 36-h continuous infusion of magnesium at 0.5 g/h, targeting serum magnesium levels between 3 and 4.8 mg/dL. In Pilot Study 2A, we administered a 6 g bolus followed by an infusion starting at 2 g/h, titrated to achieve levels between 4 and 6 mg/dL. We eliminated the bolus in Pilot Study 2B.

RESULTS

In Pilot Study 1, all five patients enrolled completed the study; however, median postoperative Mg levels were only 2.4 mg/dL. In Pilot Study 2A, two of four patients (50%) were withdrawn due to bradycardia during the bolus. In Pilot Study 2B, two patients completed the study whereas two developed postoperative bradycardia attributed to the magnesium.

CONCLUSIONS

A 0.5 g/h infusion for 36 h did not achieve therapeutic magnesium levels, while an infusion at 2 g/h was associated with bradycardia. These studies informed the design of a randomized clinical trial testing whether intravenously Mg attenuates HIOC-associated AKI.

摘要

简介

高热术中顺铂(HIOC)与急性肾损伤(AKI)有关。在动物模型中,高剂量镁的给药可减轻顺铂引起的 AKI(CP-AKI),但尚未在人类中进行严格检查。

方法

我们测试了接受 HIOC 的间皮瘤患者中不同剂量镁的可行性和安全性。在初步研究 1 中,我们以 0.5 g/h 的速度连续输注 36 小时镁,目标血清镁水平在 3 至 4.8 mg/dL 之间。在初步研究 2A 中,我们给予 6 g 推注,然后以 2 g/h 的速度开始输注,滴定以达到 4 至 6 mg/dL 的水平。我们在初步研究 2B 中消除了推注。

结果

在初步研究 1 中,所有 5 名入组患者均完成了研究;然而,术后镁中位数水平仅为 2.4 mg/dL。在初步研究 2A 中,由于推注期间心动过缓,有 4 名患者中的 2 名(50%)被撤出。在初步研究 2B 中,有两名患者完成了研究,而另外两名患者因镁而出现术后心动过缓。

结论

36 小时以 0.5 g/h 的速度输注未达到治疗性镁水平,而以 2 g/h 的速度输注则与心动过缓有关。这些研究为一项随机临床试验提供了信息,该试验测试了静脉内 Mg 是否减轻 HIOC 相关 AKI。

相似文献

1
High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.在接受术中高热顺铂治疗的间皮瘤患者中进行大剂量 IV 镁治疗的研究:试验研究和 II 期随机临床试验设计。
J Surg Oncol. 2023 Dec;128(7):1141-1149. doi: 10.1002/jso.27412. Epub 2023 Sep 13.
2
Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study).预先加载镁可减轻顺铂相关性肾毒性:初步随机对照试验(PRAGMATIC 研究)。
ESMO Open. 2022 Feb;7(1):100351. doi: 10.1016/j.esmoop.2021.100351. Epub 2021 Dec 23.
3
Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.恶性胸膜间皮瘤细胞减灭术和术中高热顺铂化疗后急性肾损伤。
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1510-1518. doi: 10.1016/j.jtcvs.2020.05.033. Epub 2020 May 29.
4
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.静脉注射镁与顺铂相关的急性肾损伤
JAMA Oncol. 2025 Apr 24. doi: 10.1001/jamaoncol.2025.0756.
5
Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.水飞蓟素给药对顺铂肾毒性的影响:一项初步、随机、双盲、安慰剂对照临床试验的报告。
Phytother Res. 2015 Jul;29(7):1046-53. doi: 10.1002/ptr.5345. Epub 2015 Apr 7.
6
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.胸膜外全肺切除术后术中胸腔内热灌注顺铂并给予药理细胞保护治疗恶性胸膜间皮瘤:一项II期前瞻性研究。
J Thorac Cardiovasc Surg. 2009 Aug;138(2):405-11. doi: 10.1016/j.jtcvs.2009.02.046.
7
Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.镁通过调节铂蓄积来预防顺铂诱导的急性肾损伤。
Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F369-84. doi: 10.1152/ajprenal.00127.2014. Epub 2014 Jun 18.
8
Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma.扩大性胸膜切除术/纤维板剥脱术及术中胸膜腔内顺铂热灌注治疗恶性胸膜间皮瘤
JTCVS Open. 2023 Sep 14;16:977-986. doi: 10.1016/j.xjon.2023.09.005. eCollection 2023 Dec.
9
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.高热术中胸膜顺铂化疗延长了低危恶性胸膜间皮瘤患者接受手术宏观完全切除术后的复发和生存间隔。
J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-963. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.
10
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.胸膜间皮瘤的手术切除和术中高热顺铂和吉西他滨的 I 期临床试验。
J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.

引用本文的文献

1
Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury.了解顺铂的药代动力学和毒代动力学以预测和预防肾损伤。
J Pharmacol Exp Ther. 2024 Nov 19;391(3):399-414. doi: 10.1124/jpet.124.002287.

本文引用的文献

1
Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.恶性胸膜间皮瘤细胞减灭术和术中高热顺铂化疗后急性肾损伤。
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1510-1518. doi: 10.1016/j.jtcvs.2020.05.033. Epub 2020 May 29.
2
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.顺铂治疗第一疗程后急性肾损伤风险预测模型的建立与验证。
J Clin Oncol. 2018 Mar 1;36(7):682-688. doi: 10.1200/JCO.2017.75.7161. Epub 2018 Jan 10.
3
Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis.血管活性药物评分在儿童脓毒症中的验证
Pediatr Crit Care Med. 2017 Aug;18(8):750-757. doi: 10.1097/PCC.0000000000001191.
4
Cisplatin nephrotoxicity: a review of the literature.顺铂肾毒性:文献综述。
J Nephrol. 2018 Feb;31(1):15-25. doi: 10.1007/s40620-017-0392-z. Epub 2017 Apr 5.
5
End Points for Clinical Trials in Acute Kidney Injury.急性肾损伤临床试验的终点指标
Am J Kidney Dis. 2017 Jan;69(1):108-116. doi: 10.1053/j.ajkd.2016.05.033. Epub 2016 Sep 3.
6
Long-Term Renal Outcomes after Cisplatin Treatment.顺铂治疗后的长期肾脏结局。
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-1179. doi: 10.2215/CJN.08070715. Epub 2016 Apr 12.
7
Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.硫酸镁在子痫前期和子痫女性中的临床药代动力学特性。
BJOG. 2016 Feb;123(3):356-66. doi: 10.1111/1471-0528.13753. Epub 2015 Nov 24.
8
Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice.镁可预防顺铂诱导的急性肾损伤,同时不影响顺铂对小鼠卵巢肿瘤异种移植瘤的杀伤作用。
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F35-47. doi: 10.1152/ajprenal.00096.2015. Epub 2015 May 6.
9
Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial.急性肾损伤的自动化电子警报:一项单盲、平行组随机对照试验
Lancet. 2015 May 16;385(9981):1966-74. doi: 10.1016/S0140-6736(15)60266-5. Epub 2015 Feb 26.
10
Prehospital use of magnesium sulfate as neuroprotection in acute stroke.院前使用硫酸镁对急性卒中进行神经保护。
N Engl J Med. 2015 Feb 5;372(6):528-36. doi: 10.1056/NEJMoa1408827.